ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
88.15
+1.50 (1.74%)
At close: Feb 27, 2026, 4:00 PM EST
85.11
-3.04 (-3.45%)
After-hours: Feb 27, 2026, 4:16 PM EST
BIB Holdings Information
BIB is an equity ETF with a total of 269 individual holdings. The top holdings are Gilead Sciences stock at 6.36%, Vertex Pharmaceuticals at 6.17%, Amgen at 6.12%, Regeneron Pharmaceuticals at 4.08%, and Alnylam Pharmaceuticals at 2.24%.
Total Holdings
269
Top 10 Percentage
31.31%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
91.44M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 6.36% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 6.17% |
| 3 | AMGN | Amgen Inc. | 6.12% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 4.08% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.24% |
| 6 | INSM | Insmed Incorporated | 1.64% |
| 7 | BIIB | Biogen Inc. | 1.41% |
| 8 | ARGX | argenx SE | 1.15% |
| 9 | UTHR | United Therapeutics Corporation | 1.11% |
| 10 | MRNA | Moderna, Inc. | 1.03% |
| 11 | ROIV | Roivant Sciences Ltd. | 1.02% |
| 12 | RVMD | Revolution Medicines, Inc. | 1.01% |
| 13 | INCY | Incyte Corporation | 1.01% |
| 14 | ILMN | Illumina, Inc. | 1.00% |
| 15 | RPRX | Royalty Pharma plc | 0.99% |
| 16 | VTRS | Viatris Inc. | 0.90% |
| 17 | ASND | Ascendis Pharma A/S | 0.72% |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 0.67% |
| 19 | BBIO | BridgeBio Pharma, Inc. | 0.67% |
| 20 | NBIX | Neurocrine Biosciences, Inc. | 0.67% |
| 21 | SNY | Sanofi | 0.66% |
| 22 | GH | Guardant Health, Inc. | 0.65% |
| 23 | MEDP | Medpace Holdings, Inc. | 0.65% |
| 24 | EXEL | Exelixis, Inc. | 0.61% |
| 25 | SMMT | Summit Therapeutics Inc. | 0.60% |
As of Feb 26, 2026